PT86321A - Procede pour la preparation d:un vaccin contre la hepatite b - Google Patents

Procede pour la preparation d:un vaccin contre la hepatite b

Info

Publication number
PT86321A
PT86321A PT86321A PT8632187A PT86321A PT 86321 A PT86321 A PT 86321A PT 86321 A PT86321 A PT 86321A PT 8632187 A PT8632187 A PT 8632187A PT 86321 A PT86321 A PT 86321A
Authority
PT
Portugal
Prior art keywords
zonal
subjected
preparation
vaccine against
against hepatitis
Prior art date
Application number
PT86321A
Other languages
English (en)
French (fr)
Other versions
PT86321B (pt
Inventor
Philippe Jean Adamowicz
Marie Noelle Mevelec
Marc Girard
Original Assignee
Pasteur Vaccins
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Vaccins filed Critical Pasteur Vaccins
Publication of PT86321A publication Critical patent/PT86321A/pt
Publication of PT86321B publication Critical patent/PT86321B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PT86321A 1986-12-10 1987-12-09 Processo para a preparacao de uma vacina contra a hepatite b PT86321B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8617265A FR2608052B1 (fr) 1986-12-10 1986-12-10 Procede de preparation d'un vaccin contre l'hepatite b et vaccin obtenu

Publications (2)

Publication Number Publication Date
PT86321A true PT86321A (fr) 1988-01-01
PT86321B PT86321B (pt) 1990-11-07

Family

ID=9341743

Family Applications (1)

Application Number Title Priority Date Filing Date
PT86321A PT86321B (pt) 1986-12-10 1987-12-09 Processo para a preparacao de uma vacina contra a hepatite b

Country Status (11)

Country Link
EP (1) EP0273811B1 (pt)
JP (1) JPS63215639A (pt)
KR (1) KR880007732A (pt)
AT (1) ATE109353T1 (pt)
CA (1) CA1306689C (pt)
DE (1) DE3750330T2 (pt)
DK (1) DK645687A (pt)
FR (1) FR2608052B1 (pt)
IL (1) IL84729A (pt)
NO (1) NO171147C (pt)
PT (1) PT86321B (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1073604A (zh) * 1991-12-01 1993-06-30 高真南 制备高免疫原性乙型肝炎疫苗的方法
WO1993012815A1 (fr) * 1991-12-27 1993-07-08 Gensci Limited Procede d'obtention d'un antigene de surface recombine de l'hepatite b, antigene et vaccin a base de celui-ci

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1356413A (en) * 1971-09-09 1974-06-12 Pfizer Ltd Method of obtaining purified australia antigen from blood serum
US4088748A (en) * 1976-11-02 1978-05-09 Merck & Co., Inc. Hepatitis B surface antigen
US4162192A (en) * 1978-09-28 1979-07-24 Juridical Foundation Method for purification of HBs antigen
FR2560890B1 (fr) * 1984-03-07 1987-10-16 Grp Genie Genetique Composition utile pour la fabrication de vaccins contenant des particules portant l'antigene de surface du virus de l'hepatite b et le recepteur de l'albumine serique humaine polymerisee, cellules animales capables de produire de telles particules et procede pour leur obtention
US4624918A (en) * 1984-07-09 1986-11-25 Genentech, Inc. Purification process for hepatitis surface antigen and product thereof
US4683294A (en) * 1985-04-03 1987-07-28 Smith Kline Rit, S.A. Process for the extraction and purification of proteins from culture media producing them

Also Published As

Publication number Publication date
DK645687A (da) 1988-06-11
KR880007732A (ko) 1988-08-29
NO875142L (no) 1988-06-13
IL84729A (en) 1993-02-21
JPS63215639A (ja) 1988-09-08
FR2608052A1 (fr) 1988-06-17
EP0273811A2 (fr) 1988-07-06
DE3750330D1 (de) 1994-09-08
ATE109353T1 (de) 1994-08-15
EP0273811A3 (en) 1988-08-03
PT86321B (pt) 1990-11-07
CA1306689C (en) 1992-08-25
DE3750330T2 (de) 1994-11-17
IL84729A0 (en) 1988-05-31
NO171147B (no) 1992-10-26
NO875142D0 (no) 1987-12-09
FR2608052B1 (fr) 1990-04-13
NO171147C (no) 1993-02-03
DK645687D0 (da) 1987-12-09
EP0273811B1 (fr) 1994-08-03

Similar Documents

Publication Publication Date Title
Tytell et al. Inducers of interferon and host resistance. 3. Double-stranded RNA from reovirus type 3 virions (reo 3-RNA).
DE3280186D1 (de) Synthese von menschlichen viralen antigenen mit hilfe von hefe.
MA21911A1 (fr) Procede pour produire une grande proteine de surface modifiee du virus de l'hepatite b .
DE3176404D1 (en) Vaccine against viral hepatitis b, method and transformed eucaryotic cells for the preparation of this vaccine
FI102616B1 (fi) Menetelmä rokotteen valmistamiseksi ihmisen parainfluenssa-viruksen tyyppiä 3 varten ja menetelmässä käytettävä ilmentämisjärjestelmä
GB8601279D0 (en) Purification of pertussis antigens
WO2002074920A3 (en) A replication-defective alphavirus vaccine linking antigen with an immunogenicity-potentiating polypeptide and a method of delivery the same
PT86321A (fr) Procede pour la preparation d:un vaccin contre la hepatite b
EP0198299A3 (en) A process for preparing hepatitis b surface antigen containing particles in novel forms which are highly immunogenic
JP3724821B2 (ja) Ａ型肝炎（ｈａｖ）の抗原およびワクチンの製造方法
AU8557491A (en) Method for obtaining recombinant surface antigen of hepatitis b virus (hep b) of higher immunogenic capacity and use thereof in a vaccine preparation
EP0315459A3 (en) Hiv incomplete particles and a method for production thereof
EP0408742B1 (en) Method for production and purification of hepatitis b vaccine
JPS57179123A (en) Purification of number viii factor-containing aqueous solution
Tanaka et al. Improved production of Epstein-Barr virus DNA for nucleic acid hybridization studies
EP0205625A1 (en) Hepatitis b virus vaccine and process for its preparation
Michel et al. Synthesis and secretion of hepatitis-B surface antigen particles in transfected animal cells.
Smith et al. Production of large quantities of32P-labeled RNA tumor virus nucleic acid
Stephenne Production in yeast and mammalian cells of the first recombinant DNA human vaccine against hepatitis B: A technical and immunological comparison.
Leboulleux et al. Loss of anti-HBc antibodies after HBV infection in immunized Senegalese children
ATE53235T1 (de) Synthese von menschlichen viralen antigenen mit hilfe von hefe.
Wu Studies on the Cultivation of Human Diploid Cells in Microcarrier Culture.
HE et al. Preliminary study on the influence of enhancer Ⅰ upon the immune response of HBV DNA vaccine
Gong A Clinical Trial of Aluminum Absorbed Hepatitis B Vaccine.
BR9705324C1 (pt) Método para produção de hbsag purificado para preparação de vacina e vacina recombinante contra a hepatite do tipo b

Legal Events

Date Code Title Description
MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19960930